or Try an Advanced Search...

    Technical Analysis for BNTX - BioNTech SE

    Grade Last Price % Change Price Change
    D 102.14 -4.00% -4.26
    BNTX closed down 4.0 percent on Wednesday, November 20, 2024, on approximately normal volume.
    7 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical BNTX trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness -4.00%
    Slingshot Bearish Bearish Swing Setup 0.27%
    Bullish Engulfing Bullish 0.27%
    Lower Bollinger Band Walk Weakness 0.27%
    Multiple of Ten Bullish Other 0.27%
    Lower Bollinger Band Touch Weakness 0.27%
    200 DMA Support Bullish 2.43%
    Doji - Bullish? Reversal 2.43%
    Multiple of Ten Bearish Other 2.43%
    BB Squeeze Ended Range Expansion 2.43%
    Older End-of-Day Signals for BNTX ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 17 hours ago
    Lower Bollinger Band Support about 17 hours ago
    Down 5% about 17 hours ago
    Down 1 ATR about 17 hours ago
    60 Minute Opening Range Breakdown about 20 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BNTX Chart by TradingView
    Basic chart:

    Profile

    BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Vaccines Allergy Biomarkers Autoimmunity In Vitro Autoimmune Disorders Immune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device

    Is BNTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 BioNTech upgraded to Outperform from In Line at Evercore ISI
    Nov 20 Moderna initiated with a Hold at Berenberg
    Nov 20 BioNTech initiated with a Buy at Berenberg
    Nov 19 Is BioNTech SE (BNTX) the Best German Stock to Buy Now?
    Nov 19 BioNTech started at buy, Moderna at hold by Berenberg
    Nov 19 BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.
    Nov 15 Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy
    Nov 15 Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
    Nov 15 Vaccine stocks drop on concerns about RFK Jr. heading HHS (update)
    Nov 15 Trump’s RFK Jr. Pick Weighs on Vaccine Makers
    See more BNTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 131.49
    52 Week Low 76.5301
    Average Volume 1,154,330
    200-Day Moving Average 95.69
    50-Day Moving Average 113.74
    20-Day Moving Average 108.67
    10-Day Moving Average 105.87
    Average True Range 5.33
    RSI (14) 41.18
    ADX 18.87
    +DI 21.62
    -DI 29.19
    Chandelier Exit (Long, 3 ATRs) 99.95
    Chandelier Exit (Short, 3 ATRs) 110.29
    Upper Bollinger Bands 116.98
    Lower Bollinger Band 100.36
    Percent B (%b) 0.11
    BandWidth 15.29
    MACD Line -2.53
    MACD Signal Line -1.78
    MACD Histogram -0.7509
    Fundamentals Value
    Market Cap 24.28 Billion
    Num Shares 238 Million
    EPS 12.15
    Price-to-Earnings (P/E) Ratio 8.41
    Price-to-Sales 3.38
    Price-to-Book 1.03
    PEG Ratio 0.04
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 109.34
    Resistance 3 (R3) 109.77 107.79 108.14
    Resistance 2 (R2) 107.79 105.96 107.58 107.74
    Resistance 1 (R1) 104.97 104.83 103.98 104.54 107.34
    Pivot Point 102.99 102.99 102.50 102.78 102.99
    Support 1 (S1) 100.17 101.16 99.18 99.74 96.94
    Support 2 (S2) 98.19 100.03 97.98 96.54
    Support 3 (S3) 95.37 98.19 96.14
    Support 4 (S4) 94.94